Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, ...
Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, ...
Source: pr-inside.com
Open Label News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Open Label. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Open Label Today - Breaking & Trending Today
Key Takeaways from Phase 4 Switch Trial Presented at AAO
Richard Adler, MD, FACS, discusses the Switch trial which compared OTX-101 (cyclosporine ophthalmic solution 0.09%) vs cyclosporine ophthalmic emulsion 0.05% (Restasis) in patients with dry eye disease (DED).
Source: ajmc.com
Key Highlights from EV-302 Study at ESMO 2023
Expert insight into the data presented at ESMO 2023 on the EV-302 study of enfortumab vedotin and pembrolizumab in the management of locally advanced or metastatic urothelial carcinoma.
Source: ajmc.com
Much of U.S. Healthcare Is Broken: How to Fix It (Chapter 1, Part 1)
Les Ruthven addresses the difference between basing a medical system on clinical belief versus one based on scientific evidence.
Source: madinamerica.com
Data Considerations of Novel Immunotherapies for IgAN
Cheung shares his approach to using novel immunotherapies in IgAN to prevent infection.
Source: hcplive.com